img

Global Japanese Encephalitis Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Japanese Encephalitis Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Epidemic encephalitis (JE) is a disease spreads through mosquito bites. Symptoms usually take 5-15 days to develop and include fever, headache, vomiting, confusion, and difficulty moving. The major form of the disease is encephalitis, and less severe forms such as aseptic meningitis or simple fever syndrome with headache are also frequent. The mortality rate of Japanese encephalitis is high, and sequelae are very common, especially among children (up to 50%). Prevention is possible through the use of inactivated vaccines.
Japanese Encephalitis Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Japanese Encephalitis Vaccines market is projected to reach US$ 300.3 million in 2034, increasing from US$ 208.6 million in 2022, with the CAGR of 5.3% during the period of 2024 to 2034. Demand from Adults and Children are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Japanese Encephalitis Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Japanese Encephalitis Vaccines key manufacturers include Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, China National Biotec Group and Valneva Products, etc. Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech are top 3 players and held % sales share in total in 2022.
Japanese Encephalitis Vaccines can be divided into Attenuated Vaccines and Inactivated Vaccines, etc. Attenuated Vaccines is the mainstream product in the market, accounting for % sales share globally in 2022.
Japanese Encephalitis Vaccines is widely used in various fields, such as Adults and Children, etc. Adults provides greatest supports to the Japanese Encephalitis Vaccines industry development. In 2022, global % sales of Japanese Encephalitis Vaccines went into Adults filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Japanese Encephalitis Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi Pasteur
GlaxoSmithKline
Bharat Biotech
China National Biotec Group
Valneva Products
Segment by Type
Attenuated Vaccines
Inactivated Vaccines

Segment by Application


Adults
Children

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Japanese Encephalitis Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Japanese Encephalitis Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Japanese Encephalitis Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Japanese Encephalitis Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Japanese Encephalitis Vaccines introduction, etc. Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Japanese Encephalitis Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Japanese Encephalitis Vaccines Market Overview
1.1 Japanese Encephalitis Vaccines Product Overview
1.2 Japanese Encephalitis Vaccines Market Segment by Type
1.2.1 Attenuated Vaccines
1.2.2 Inactivated Vaccines
1.3 Global Japanese Encephalitis Vaccines Market Size by Type
1.3.1 Global Japanese Encephalitis Vaccines Market Size Overview by Type (2018-2034)
1.3.2 Global Japanese Encephalitis Vaccines Historic Market Size Review by Type (2018-2024)
1.3.3 Global Japanese Encephalitis Vaccines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Japanese Encephalitis Vaccines Sales Breakdown by Type (2018-2024)
1.4.2 Europe Japanese Encephalitis Vaccines Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Japanese Encephalitis Vaccines Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Japanese Encephalitis Vaccines Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Japanese Encephalitis Vaccines Sales Breakdown by Type (2018-2024)
2 Global Japanese Encephalitis Vaccines Market Competition by Company
2.1 Global Top Players by Japanese Encephalitis Vaccines Sales (2018-2024)
2.2 Global Top Players by Japanese Encephalitis Vaccines Revenue (2018-2024)
2.3 Global Top Players by Japanese Encephalitis Vaccines Price (2018-2024)
2.4 Global Top Manufacturers Japanese Encephalitis Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Japanese Encephalitis Vaccines Market Competitive Situation and Trends
2.5.1 Japanese Encephalitis Vaccines Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Japanese Encephalitis Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Japanese Encephalitis Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Japanese Encephalitis Vaccines Market
2.8 Key Manufacturers Japanese Encephalitis Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Japanese Encephalitis Vaccines Status and Outlook by Region
3.1 Global Japanese Encephalitis Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Japanese Encephalitis Vaccines Historic Market Size by Region
3.2.1 Global Japanese Encephalitis Vaccines Sales in Volume by Region (2018-2024)
3.2.2 Global Japanese Encephalitis Vaccines Sales in Value by Region (2018-2024)
3.2.3 Global Japanese Encephalitis Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Japanese Encephalitis Vaccines Forecasted Market Size by Region
3.3.1 Global Japanese Encephalitis Vaccines Sales in Volume by Region (2024-2034)
3.3.2 Global Japanese Encephalitis Vaccines Sales in Value by Region (2024-2034)
3.3.3 Global Japanese Encephalitis Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Japanese Encephalitis Vaccines by Application
4.1 Japanese Encephalitis Vaccines Market Segment by Application
4.1.1 Adults
4.1.2 Children
4.2 Global Japanese Encephalitis Vaccines Market Size by Application
4.2.1 Global Japanese Encephalitis Vaccines Market Size Overview by Application (2018-2034)
4.2.2 Global Japanese Encephalitis Vaccines Historic Market Size Review by Application (2018-2024)
4.2.3 Global Japanese Encephalitis Vaccines Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Japanese Encephalitis Vaccines Sales Breakdown by Application (2018-2024)
4.3.2 Europe Japanese Encephalitis Vaccines Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Japanese Encephalitis Vaccines Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Japanese Encephalitis Vaccines Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Japanese Encephalitis Vaccines Sales Breakdown by Application (2018-2024)
5 North America Japanese Encephalitis Vaccines by Country
5.1 North America Japanese Encephalitis Vaccines Historic Market Size by Country
5.1.1 North America Japanese Encephalitis Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Japanese Encephalitis Vaccines Sales in Volume by Country (2018-2024)
5.1.3 North America Japanese Encephalitis Vaccines Sales in Value by Country (2018-2024)
5.2 North America Japanese Encephalitis Vaccines Forecasted Market Size by Country
5.2.1 North America Japanese Encephalitis Vaccines Sales in Volume by Country (2024-2034)
5.2.2 North America Japanese Encephalitis Vaccines Sales in Value by Country (2024-2034)
6 Europe Japanese Encephalitis Vaccines by Country
6.1 Europe Japanese Encephalitis Vaccines Historic Market Size by Country
6.1.1 Europe Japanese Encephalitis Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Japanese Encephalitis Vaccines Sales in Volume by Country (2018-2024)
6.1.3 Europe Japanese Encephalitis Vaccines Sales in Value by Country (2018-2024)
6.2 Europe Japanese Encephalitis Vaccines Forecasted Market Size by Country
6.2.1 Europe Japanese Encephalitis Vaccines Sales in Volume by Country (2024-2034)
6.2.2 Europe Japanese Encephalitis Vaccines Sales in Value by Country (2024-2034)
7 Asia-Pacific Japanese Encephalitis Vaccines by Region
7.1 Asia-Pacific Japanese Encephalitis Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Japanese Encephalitis Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Japanese Encephalitis Vaccines Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Japanese Encephalitis Vaccines Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Japanese Encephalitis Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Japanese Encephalitis Vaccines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Japanese Encephalitis Vaccines Sales in Value by Region (2024-2034)
8 Latin America Japanese Encephalitis Vaccines by Country
8.1 Latin America Japanese Encephalitis Vaccines Historic Market Size by Country
8.1.1 Latin America Japanese Encephalitis Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Japanese Encephalitis Vaccines Sales in Volume by Country (2018-2024)
8.1.3 Latin America Japanese Encephalitis Vaccines Sales in Value by Country (2018-2024)
8.2 Latin America Japanese Encephalitis Vaccines Forecasted Market Size by Country
8.2.1 Latin America Japanese Encephalitis Vaccines Sales in Volume by Country (2024-2034)
8.2.2 Latin America Japanese Encephalitis Vaccines Sales in Value by Country (2024-2034)
9 Middle East and Africa Japanese Encephalitis Vaccines by Country
9.1 Middle East and Africa Japanese Encephalitis Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Japanese Encephalitis Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Japanese Encephalitis Vaccines Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Japanese Encephalitis Vaccines Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Japanese Encephalitis Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Japanese Encephalitis Vaccines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Japanese Encephalitis Vaccines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Sanofi Pasteur
10.1.1 Sanofi Pasteur Company Information
10.1.2 Sanofi Pasteur Introduction and Business Overview
10.1.3 Sanofi Pasteur Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sanofi Pasteur Japanese Encephalitis Vaccines Products Offered
10.1.5 Sanofi Pasteur Recent Development
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Company Information
10.2.2 GlaxoSmithKline Introduction and Business Overview
10.2.3 GlaxoSmithKline Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.2.4 GlaxoSmithKline Japanese Encephalitis Vaccines Products Offered
10.2.5 GlaxoSmithKline Recent Development
10.3 Bharat Biotech
10.3.1 Bharat Biotech Company Information
10.3.2 Bharat Biotech Introduction and Business Overview
10.3.3 Bharat Biotech Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Bharat Biotech Japanese Encephalitis Vaccines Products Offered
10.3.5 Bharat Biotech Recent Development
10.4 China National Biotec Group
10.4.1 China National Biotec Group Company Information
10.4.2 China National Biotec Group Introduction and Business Overview
10.4.3 China National Biotec Group Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.4.4 China National Biotec Group Japanese Encephalitis Vaccines Products Offered
10.4.5 China National Biotec Group Recent Development
10.5 Valneva Products
10.5.1 Valneva Products Company Information
10.5.2 Valneva Products Introduction and Business Overview
10.5.3 Valneva Products Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Valneva Products Japanese Encephalitis Vaccines Products Offered
10.5.5 Valneva Products Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Japanese Encephalitis Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Japanese Encephalitis Vaccines Industrial Chain Analysis
11.4 Japanese Encephalitis Vaccines Market Dynamics
11.4.1 Japanese Encephalitis Vaccines Industry Trends
11.4.2 Japanese Encephalitis Vaccines Market Drivers
11.4.3 Japanese Encephalitis Vaccines Market Challenges
11.4.4 Japanese Encephalitis Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Japanese Encephalitis Vaccines Distributors
12.3 Japanese Encephalitis Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Attenuated Vaccines
Table 2. Major Company of Inactivated Vaccines
Table 3. Global Japanese Encephalitis Vaccines Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Japanese Encephalitis Vaccines Sales by Type (2018-2024) & (K Doses)
Table 5. Global Japanese Encephalitis Vaccines Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Japanese Encephalitis Vaccines Sales by Type (2018-2024) & (US& Million)
Table 7. Global Japanese Encephalitis Vaccines Market Share in Value by Type (2018-2024)
Table 8. Global Japanese Encephalitis Vaccines Price by Type (2018-2024) & (USD/Dose)
Table 9. Global Japanese Encephalitis Vaccines Sales by Type (2024-2034) & (K Doses)
Table 10. Global Japanese Encephalitis Vaccines Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Japanese Encephalitis Vaccines Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Japanese Encephalitis Vaccines Sales Market Share in Value by Type (2024-2034)
Table 13. Global Japanese Encephalitis Vaccines Price by Type (2024-2034) & (USD/Dose)
Table 14. North America Japanese Encephalitis Vaccines Sales by Type (2018-2024) & (K Doses)
Table 15. North America Japanese Encephalitis Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Japanese Encephalitis Vaccines Sales (K Doses) by Type (2018-2024)
Table 17. Europe Japanese Encephalitis Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Japanese Encephalitis Vaccines Sales (K Doses) by Type (2018-2024)
Table 19. Asia-Pacific Japanese Encephalitis Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Japanese Encephalitis Vaccines Sales (K Doses) by Type (2018-2024)
Table 21. Latin America Japanese Encephalitis Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Japanese Encephalitis Vaccines Sales (K Doses) by Type (2018-2024)
Table 23. Middle East and Africa Japanese Encephalitis Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Japanese Encephalitis Vaccines Sales by Company (2018-2024) & (K Doses)
Table 25. Global Japanese Encephalitis Vaccines Sales Share by Company (2018-2024)
Table 26. Global Japanese Encephalitis Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Japanese Encephalitis Vaccines Revenue Share by Company (2018-2024)
Table 28. Global Market Japanese Encephalitis Vaccines Price by Company (2018-2024) & (USD/Dose)
Table 29. Global Japanese Encephalitis Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Japanese Encephalitis Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Japanese Encephalitis Vaccines as of 2022)
Table 32. Date of Key Manufacturers Enter into Japanese Encephalitis Vaccines Market
Table 33. Key Manufacturers Japanese Encephalitis Vaccines Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Japanese Encephalitis Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Japanese Encephalitis Vaccines Sales by Region (2018-2024) & (K Doses)
Table 37. Global Japanese Encephalitis Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Japanese Encephalitis Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Japanese Encephalitis Vaccines Sales Market Share in Value by Region (2018-2024)
Table 40. Global Japanese Encephalitis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 41. Global Japanese Encephalitis Vaccines Sales by Region (2024-2034) & (K Doses)
Table 42. Global Japanese Encephalitis Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Japanese Encephalitis Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Japanese Encephalitis Vaccines Sales Market Share in Value by Region (2024-2034)
Table 45. Global Japanese Encephalitis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2034)
Table 46. Global Japanese Encephalitis Vaccines Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Japanese Encephalitis Vaccines Sales by Application (2018-2024) & (K Doses)
Table 48. Global Japanese Encephalitis Vaccines Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Japanese Encephalitis Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Japanese Encephalitis Vaccines Sales Market Share in Value by Application (2018-2024)
Table 51. Global Japanese Encephalitis Vaccines Price by Application (2018-2024) & (USD/Dose)
Table 52. Global Japanese Encephalitis Vaccines Sales by Application (2024-2034) & (K Doses)
Table 53. Global Japanese Encephalitis Vaccines Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Japanese Encephalitis Vaccines Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Japanese Encephalitis Vaccines Sales Market Share in Value by Application (2024-2034)
Table 56. Global Japanese Encephalitis Vaccines Price by Application (2024-2034) & (USD/Dose)
Table 57. North America Japanese Encephalitis Vaccines Sales by Application (2018-2024) (K Doses)
Table 58. North America Japanese Encephalitis Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Japanese Encephalitis Vaccines Sales by Application (2018-2024) (K Doses)
Table 60. Europe Japanese Encephalitis Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Japanese Encephalitis Vaccines Sales by Application (2018-2024) (K Doses)
Table 62. Asia-Pacific Japanese Encephalitis Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Japanese Encephalitis Vaccines Sales by Application (2018-2024) (K Doses)
Table 64. Latin America Japanese Encephalitis Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Japanese Encephalitis Vaccines Sales by Application (2018-2024) (K Doses)
Table 66. Middle East and Africa Japanese Encephalitis Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Japanese Encephalitis Vaccines Sales by Country (2018-2024) & (K Doses)
Table 68. North America Japanese Encephalitis Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Japanese Encephalitis Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Japanese Encephalitis Vaccines Sales Market Share in Value by Country (2018-2024)
Table 71. North America Japanese Encephalitis Vaccines Sales by Country (2024-2034) & (K Doses)
Table 72. North America Japanese Encephalitis Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Japanese Encephalitis Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Japanese Encephalitis Vaccines Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Japanese Encephalitis Vaccines Sales by Country (2018-2024) & (K Doses)
Table 76. Europe Japanese Encephalitis Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Japanese Encephalitis Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Japanese Encephalitis Vaccines Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Japanese Encephalitis Vaccines Sales by Country (2024-2034) & (K Doses)
Table 80. Europe Japanese Encephalitis Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Japanese Encephalitis Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Japanese Encephalitis Vaccines Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Japanese Encephalitis Vaccines Sales by Region (2018-2024) & (K Doses)
Table 84. Asia-Pacific Japanese Encephalitis Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Japanese Encephalitis Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Japanese Encephalitis Vaccines Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Japanese Encephalitis Vaccines Sales by Region (2024-2034) & (K Doses)
Table 88. Asia-Pacific Japanese Encephalitis Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Japanese Encephalitis Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Japanese Encephalitis Vaccines Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Japanese Encephalitis Vaccines Sales by Country (2018-2024) & (K Doses)
Table 92. Latin America Japanese Encephalitis Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Japanese Encephalitis Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Japanese Encephalitis Vaccines Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Japanese Encephalitis Vaccines Sales by Country (2024-2034) & (K Doses)
Table 96. Latin America Japanese Encephalitis Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Japanese Encephalitis Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Japanese Encephalitis Vaccines Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Japanese Encephalitis Vaccines Sales by Country (2018-2024) & (K Doses)
Table 100. Middle East and Africa Japanese Encephalitis Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Japanese Encephalitis Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Japanese Encephalitis Vaccines Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Japanese Encephalitis Vaccines Sales by Country (2024-2034) & (K Doses)
Table 104. Middle East and Africa Japanese Encephalitis Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Japanese Encephalitis Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Japanese Encephalitis Vaccines Sales Market Share in Value by Country (2024-2034)
Table 107. Sanofi Pasteur Company Information
Table 108. Sanofi Pasteur Introduction and Business Overview
Table 109. Sanofi Pasteur Japanese Encephalitis Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 110. Sanofi Pasteur Japanese Encephalitis Vaccines Product
Table 111. Sanofi Pasteur Recent Development
Table 112. GlaxoSmithKline Company Information
Table 113. GlaxoSmithKline Introduction and Business Overview
Table 114. GlaxoSmithKline Japanese Encephalitis Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 115. GlaxoSmithKline Japanese Encephalitis Vaccines Product
Table 116. GlaxoSmithKline Recent Development
Table 117. Bharat Biotech Company Information
Table 118. Bharat Biotech Introduction and Business Overview
Table 119. Bharat Biotech Japanese Encephalitis Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 120. Bharat Biotech Japanese Encephalitis Vaccines Product
Table 121. Bharat Biotech Recent Development
Table 122. China National Biotec Group Company Information
Table 123. China National Biotec Group Introduction and Business Overview
Table 124. China National Biotec Group Japanese Encephalitis Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 125. China National Biotec Group Japanese Encephalitis Vaccines Product
Table 126. China National Biotec Group Recent Development
Table 127. Valneva Products Company Information
Table 128. Valneva Products Introduction and Business Overview
Table 129. Valneva Products Japanese Encephalitis Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 130. Valneva Products Japanese Encephalitis Vaccines Product
Table 131. Valneva Products Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Japanese Encephalitis Vaccines Market Trends
Table 135. Japanese Encephalitis Vaccines Market Drivers
Table 136. Japanese Encephalitis Vaccines Market Challenges
Table 137. Japanese Encephalitis Vaccines Market Restraints
Table 138. Japanese Encephalitis Vaccines Distributors List
Table 139. Japanese Encephalitis Vaccines Downstream Customers
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Japanese Encephalitis Vaccines Product Picture
Figure 2. Global Japanese Encephalitis Vaccines Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Japanese Encephalitis Vaccines Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Japanese Encephalitis Vaccines Sales Status and Outlook (2018-2034) & (K Doses)
Figure 5. Product Picture of Attenuated Vaccines
Figure 6. Global Attenuated Vaccines Sales YoY Growth (2018-2034) & (K Doses)
Figure 7. Product Picture of Inactivated Vaccines
Figure 8. Global Inactivated Vaccines Sales YoY Growth (2018-2034) & (K Doses)
Figure 9. Global Japanese Encephalitis Vaccines Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Japanese Encephalitis Vaccines Sales Market Share by Type in 2022 & 2034
Figure 11. North America Japanese Encephalitis Vaccines Sales Market Share in Volume by Type in 2022
Figure 12. North America Japanese Encephalitis Vaccines Sales Market Share in Value by Type in 2022
Figure 13. Europe Japanese Encephalitis Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. Europe Japanese Encephalitis Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Japanese Encephalitis Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Japanese Encephalitis Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Latin America Japanese Encephalitis Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Japanese Encephalitis Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Japanese Encephalitis Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Japanese Encephalitis Vaccines Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Japanese Encephalitis Vaccines Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Japanese Encephalitis Vaccines Revenue in 2022
Figure 23. Japanese Encephalitis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Adults
Figure 25. Global Adults Sales YoY Growth (2018-2034) & (K Doses)
Figure 26. Product Picture of Children
Figure 27. Global Children Sales YoY Growth (2018-2034) & (K Doses)
Figure 28. Global Japanese Encephalitis Vaccines Sales by Application (2018-2034) & (US$ Million)
Figure 29. Global Japanese Encephalitis Vaccines Sales Market Share by Application in 2022 & 2034
Figure 30. North America Japanese Encephalitis Vaccines Sales Market Share in Volume by Application in 2022
Figure 31. North America Japanese Encephalitis Vaccines Sales Market Share in Value by Application in 2022
Figure 32. Europe Japanese Encephalitis Vaccines Sales Market Share in Volume by Application in 2022
Figure 33. Europe Japanese Encephalitis Vaccines Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Japanese Encephalitis Vaccines Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Japanese Encephalitis Vaccines Sales Market Share in Value by Application in 2022
Figure 36. Latin America Japanese Encephalitis Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Japanese Encephalitis Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Japanese Encephalitis Vaccines Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Japanese Encephalitis Vaccines Manufacturing Cost Structure
Figure 41. Japanese Encephalitis Vaccines Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries